What is hemolytic anemia?

What is Hemolytic Anemia

Hemolytic anemia is a condition characterized by the premature destruction of red blood cells (RBCs), resulting in decreased circulating erythrocytes and a shortened red cell lifespan, which can manifest as either severe anemia or compensated hemolysis accompanied by reticulocytosis. 1

Core Pathophysiology

Hemolytic anemia occurs when RBC destruction outpaces bone marrow production capacity. The destruction can occur through two primary mechanisms 1:

• Intravascular hemolysis: RBCs are destroyed within the circulation
• Extravascular hemolysis: RBCs are trapped and destroyed in the reticuloendothelial system (primarily spleen and liver) 1

Mechanisms of Red Cell Destruction

The premature destruction of erythrocytes occurs through several pathways 1:

• Poor deformability leading to trapping and phagocytosis in the spleen
• Antibody-mediated destruction through phagocytosis or direct complement activation
• Fragmentation due to microthrombi or direct mechanical trauma
• Oxidative damage to cellular components
• Direct cellular destruction by infectious agents or toxins 1

Clinical Presentation

Patients with hemolysis typically present with 1, 2:

• Acute or chronic anemia with associated fatigue and weakness
• Jaundice from elevated unconjugated bilirubin
• Hematuria (in intravascular hemolysis)
• Dyspnea and tachycardia from reduced oxygen-carrying capacity
• Splenomegaly (particularly in extravascular hemolysis) 3
• Hypotension in severe acute cases 1

Laboratory Hallmarks

The diagnosis is established by characteristic laboratory findings 1, 2:

Markers Confirming Hemolysis

• Reticulocytosis: Elevated reticulocyte count indicating compensatory bone marrow response 3
• Increased lactate dehydrogenase (LDH): Released from destroyed RBCs 3
• Decreased haptoglobin: Consumed by binding free hemoglobin 3
• Elevated unconjugated (indirect) bilirubin: From heme catabolism, typically <5 mg/dL in chronic cases 3

Additional Findings

• Normocytic or macrocytic anemia on complete blood count 1
• Peripheral blood smear abnormalities: May show schistocytes, spherocytes, or other morphologic changes depending on etiology 1

Major Classifications

Hemolytic anemias are broadly categorized into 1, 2:

Hereditary Causes

• Hemoglobinopathies: Sickle cell disease, thalassemias 2
• Membranopathies: Hereditary spherocytosis, hereditary elliptocytosis 2
• Enzymopathies: Glucose-6-phosphate dehydrogenase (G6PD) deficiency, pyruvate kinase deficiency 3, 2

Acquired Causes

• Immune-mediated: Autoimmune hemolytic anemia (warm or cold antibody types), drug-induced 1, 2, 4
• Microangiopathic: Thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), disseminated intravascular coagulation (DIC) 1
• Infectious: Malaria, babesiosis 2
• Direct trauma: Mechanical heart valves, march hemoglobinuria 1
• Oxidative insults: Medications, toxins 1

Diagnostic Approach

The workup follows a systematic algorithm 3:

1. Confirm hemolysis with reticulocytosis, elevated LDH, decreased haptoglobin, and elevated indirect bilirubin 3

2. Perform direct antiglobulin test (DAT) to differentiate immune from non-immune causes 1

3. Examine peripheral blood smear for morphologic clues to specific etiologies 1

4. Exclude acquired causes: Rule out immune-mediated processes, infections, and microangiopathic causes 3

5. Consider hereditary causes when acquired causes are excluded, particularly in chronic cases with family history 3

6. Genetic testing when conventional tests fail to identify the cause 5

Important Clinical Caveats

Several pitfalls warrant attention 3:

• Reticulocytosis may be inappropriately low in some hereditary hemolytic anemias (like pyruvate kinase deficiency) due to splenic sequestration of young RBCs or ineffective erythropoiesis 3

• Recent blood transfusions can mask diagnostic findings and should be documented 3

• Red cell morphology may be unremarkable in certain enzymopathies, unlike membranopathies where spherocytes or other characteristic shapes are typically present 3

• Neonatal presentation with severe hyperbilirubinemia or unexplained anemia should prompt immediate consideration of hemolytic causes 3, 1